Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2030 USD
−15.80 M USD
0.00 USD
25.73 M
About MYDECINE INNOVATIONS GROUP INC.
Sector
CEO
David Joshua Bartch
Headquarters
Vancouver
Website
Founded
2013
FIGI
BBG00864XZL0
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MYCOF is 0.0054 USD — it has decreased by −0.92% in the past 24 hours. Watch MYDECINE INNOVATIONS GROUP INC NEW stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MYDECINE INNOVATIONS GROUP INC NEW stocks are traded under the ticker MYCOF.
MYCOF stock has fallen by −7.69% compared to the previous week, the month change is a −46.00% fall, over the last year MYDECINE INNOVATIONS GROUP INC NEW has showed a −89.49% decrease.
MYCOF reached its all-time high on Dec 29, 2017 with the price of 742.5000 USD, and its all-time low was 0.0001 USD and was reached on Mar 4, 2024. View more price dynamics on MYCOF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MYCOF stock is 60.00% volatile and has beta coefficient of 6.77. Track MYDECINE INNOVATIONS GROUP INC NEW stock price on the chart and check out the list of the most volatile stocks — is MYDECINE INNOVATIONS GROUP INC NEW there?
Yes, you can track MYDECINE INNOVATIONS GROUP INC NEW financials in yearly and quarterly reports right on TradingView.
MYDECINE INNOVATIONS GROUP INC NEW is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
MYCOF net income for the last quarter is −1.47 M USD, while the quarter before that showed −1.95 M USD of net income which accounts for 24.55% change. Track more MYDECINE INNOVATIONS GROUP INC NEW financial stats to get the full picture.
No, MYCOF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYCOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC NEW stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYDECINE INNOVATIONS GROUP INC NEW technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYDECINE INNOVATIONS GROUP INC NEW stock shows the sell signal. See more of MYDECINE INNOVATIONS GROUP INC NEW technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.